• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ诱导蛋白-10(IP-10)和肿瘤坏死因子-α(TNF-α)作为局限性硬皮病活动疾病状态的血清学预测指标。

Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.

机构信息

Department of Pediatrics (Rheumatology), University of Pittsburgh, Pittsburgh, PA 15224, USA.

Department of Physical Medicine & Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.

出版信息

Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134.

DOI:10.3390/ijms251810134
PMID:39337619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11432045/
Abstract

We investigated the ability of a panel of immune-related cytokines and chemokines to predict the disease activity state in localized scleroderma (LS) subjects followed longitudinally. A total of 194 sera samples were obtained from 45 LS subjects with diverse types of LS (40% linear, 20% mixed, 16% craniofacial, 13% generalized, and 11% circumscribed) in our cohort. Cytokines/chemokines that were significantly elevated at the baseline active disease visit compared to the inactive disease state at follow-up were Interferon-Gamma-Inducible Protein (IP)-10 ( < 0.021) and Tumor Necrosis Factor (TNF)-α ( < 0.033). Mixed effect logit modeling identified IP-10 (Odds Ratio (OR) [95% confidence interval] = 2.1 [1.4, 3.2], < 0.001), TNF-α (OR = 1.8 [1.1, 3.0], = 0.016), and Monocyte Chemoattractant Protein (MCP)-1 (OR = 2.0 [1.1, 3.9], = 0.034) as significant predictors of active disease status. These findings support earlier correlations between IP-10 and TNF-α with disease activity parameters in a cross-sectional Luminex™ serological study and may enhance clinical decision-making when disease activity is challenging to assess by clinical examination alone.

摘要

我们研究了一组免疫相关细胞因子和趋化因子的能力,以预测在我们的队列中接受纵向随访的局限性硬皮病(LS)患者的疾病活动状态。共从 45 名具有不同类型 LS(40%线状、20%混合性、16%头面部、13%全身性和 11%局限性)的 LS 患者中获得了 194 份血清样本。与后续无活动疾病状态相比,基线活动疾病就诊时显著升高的细胞因子/趋化因子为干扰素γ诱导蛋白(IP)-10(<0.021)和肿瘤坏死因子(TNF)-α(<0.033)。混合效应逻辑回归模型确定 IP-10(优势比(OR)[95%置信区间] = 2.1 [1.4, 3.2],<0.001)、TNF-α(OR = 1.8 [1.1, 3.0],= 0.016)和单核细胞趋化蛋白(MCP)-1(OR = 2.0 [1.1, 3.9],= 0.034)是疾病活动状态的显著预测因子。这些发现支持在横断面 Luminex™血清学研究中 IP-10 和 TNF-α与疾病活动参数之间的早期相关性,并可能增强在仅通过临床检查评估疾病活动存在挑战时的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1c/11432045/8fb381eeb49e/ijms-25-10134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1c/11432045/8fb381eeb49e/ijms-25-10134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e1c/11432045/8fb381eeb49e/ijms-25-10134-g001.jpg

相似文献

1
Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.干扰素-γ诱导蛋白-10(IP-10)和肿瘤坏死因子-α(TNF-α)作为局限性硬皮病活动疾病状态的血清学预测指标。
Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134.
2
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.青少年局限性硬皮病外周血细胞因子和趋化因子谱:辅助性T细胞相关细胞因子谱
Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17.
3
Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.干扰素-γ诱导蛋白10作为局限性硬皮病的潜在生物标志物
Arthritis Res Ther. 2013;15(6):R188. doi: 10.1186/ar4378.
4
Interferons dominate damage and activity in juvenile scleroderma.干扰素主导幼年硬皮病的损害和活动。
Mod Rheumatol. 2024 Oct 15;34(6):1178-1184. doi: 10.1093/mr/roae032.
5
Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis.血清趋化因子和细胞因子水平作为系统性硬化症患者疾病活动的指标。
Clin Rheumatol. 2011 Feb;30(2):231-7. doi: 10.1007/s10067-010-1610-4. Epub 2010 Nov 4.
6
Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.血清 IP-10 可用于识别儿童系统性红斑狼疮的肾脏和整体疾病活动。
Pediatr Nephrol. 2018 May;33(5):837-845. doi: 10.1007/s00467-017-3867-1. Epub 2017 Dec 20.
7
Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis.依那西普治疗可降低类风湿关节炎患者血清中白细胞介素-15 和干扰素-γ诱导蛋白-10 的水平。
Rheumatol Int. 2010 Apr;30(6):725-30. doi: 10.1007/s00296-009-1356-y. Epub 2010 Jan 10.
8
Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.可溶性 TNF-R1、VEGF 和其他细胞因子作为系统性红斑狼疮和狼疮性肾炎疾病活动的标志物。
Lupus. 2019 May;28(6):713-721. doi: 10.1177/0961203319845487. Epub 2019 May 2.
9
Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.评估 IP-10 和 IL-2 作为卡介苗接种人群中活动性和潜伏性结核病诊断标志物的诊断潜力。
PLoS One. 2012;7(12):e51338. doi: 10.1371/journal.pone.0051338. Epub 2012 Dec 14.
10
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.肿瘤坏死因子-α和干扰素-γ,而非人嗜T淋巴细胞病毒I型反式激活蛋白(HTLV-I tax),可能通过诱导干扰素诱导蛋白-10成为皮肤T细胞淋巴瘤亲表皮性的相关因素。
Leuk Lymphoma. 1998 Apr;29(3-4):315-28. doi: 10.3109/10428199809068568.

本文引用的文献

1
Interferons dominate damage and activity in juvenile scleroderma.干扰素主导幼年硬皮病的损害和活动。
Mod Rheumatol. 2024 Oct 15;34(6):1178-1184. doi: 10.1093/mr/roae032.
2
Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.单细胞转录组分析鉴定局限性硬皮病中具有炎症性成纤维细胞反应的亚群。
Int J Mol Sci. 2023 Jun 6;24(12):9796. doi: 10.3390/ijms24129796.
3
CXCL9 Links Skin Inflammation and Fibrosis through CXCR3-Dependent Upregulation of Col1a1 in Fibroblasts.
CXCL9 通过 CXCR3 依赖性上调成纤维细胞 Col1a1 介导皮肤炎症和纤维化。
J Invest Dermatol. 2023 Jul;143(7):1138-1146.e12. doi: 10.1016/j.jid.2022.11.025. Epub 2023 Jan 25.
4
Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea.局限性硬皮病患者血清中特定白细胞介素-1家族细胞因子的水平
J Clin Med. 2022 Oct 28;11(21):6375. doi: 10.3390/jcm11216375.
5
Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease.幼年局限性硬皮病:与成人发病疾病的更新和差异。
Rheum Dis Clin North Am. 2021 Nov;47(4):737-755. doi: 10.1016/j.rdc.2021.07.014. Epub 2021 Sep 2.
6
Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin.儿童局限性硬皮病皮肤RNA测序的基因特征
Front Pediatr. 2021 Jun 7;9:669116. doi: 10.3389/fped.2021.669116. eCollection 2021.
7
Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation.组织学与临床相关性评价儿童局限性硬皮病皮肤的转录组学研究。
Arthritis Rheumatol. 2021 Oct;73(10):1921-1930. doi: 10.1002/art.41758. Epub 2021 Aug 31.
8
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.肿瘤坏死因子α(TNF-α)在自身免疫性疾病中的作用及目前 TNF-α 抑制剂在治疗中的应用。
Int J Mol Sci. 2021 Mar 8;22(5):2719. doi: 10.3390/ijms22052719.
9
Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.皮肤外表现常见,与疾病活动时间延长和幼年局限性硬皮病的影响更大相关。
Rheumatology (Oxford). 2021 Dec 1;60(12):5724-5733. doi: 10.1093/rheumatology/keab238.
10
Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.儿童关节炎与风湿病研究联盟遗产登记处青少年局限性硬皮病亚组的基线描述。
ACR Open Rheumatol. 2019 Apr 10;1(2):119-124. doi: 10.1002/acr2.1019. eCollection 2019 Apr.